Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Hilleman

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Pharmacotherapy|September 1, 1993
Assessing the treatment of congestive heart failure: inotropic agents and calcium channel blockersD E Hilleman
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 13, 2000
Role of angiotensin-converting-enzyme inhibitors in the treatment of hypertensionD E Hilleman
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 24, 1998
Management of peripheral arterial diseaseD E Hilleman
The Chronicle|February 1, 1982
ZomaxD E Hilleman
Pharmacoeconomics|April 17, 2001
Economic burden of chronic obstructive pulmonary disease. Impact of new treatment optionsM Friedman, D E Hilleman
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|August 6, 1992
Issues in contemporary drug delivery. Part VI: Advanced cardiac drug formulationsD E Hilleman, U V Banakar
The Annals of Pharmacotherapy|June 1, 1995
Media sensationalism of clinical trials: freedom of information or potential for causing patient harm?B D Lucas, D E Hilleman
DICP : the Annals of Pharmacotherapy|October 1, 1991
Reducing time delays in the administration of thrombolytic therapy to patients with acute myocardial infarctionD E Hilleman, J M Gannon
The Annals of Pharmacotherapy|December 1, 2000
Aggrenox: a fixed-dose combination of aspirin and dipyridamoleT L Lenz, D E Hilleman
Pharmacotherapy|May 15, 2001
Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based reviewD E Hilleman, A L Bauman
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Pharmacotherapy|September 1, 1993
Assessing the treatment of congestive heart failure: inotropic agents and calcium channel blockersD E Hilleman
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 13, 2000
Role of angiotensin-converting-enzyme inhibitors in the treatment of hypertensionD E Hilleman
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 24, 1998
Management of peripheral arterial diseaseD E Hilleman
The Chronicle|February 1, 1982
ZomaxD E Hilleman
Pharmacoeconomics|April 17, 2001
Economic burden of chronic obstructive pulmonary disease. Impact of new treatment optionsM Friedman, D E Hilleman
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|August 6, 1992
Issues in contemporary drug delivery. Part VI: Advanced cardiac drug formulationsD E Hilleman, U V Banakar
The Annals of Pharmacotherapy|June 1, 1995
Media sensationalism of clinical trials: freedom of information or potential for causing patient harm?B D Lucas, D E Hilleman
DICP : the Annals of Pharmacotherapy|October 1, 1991
Reducing time delays in the administration of thrombolytic therapy to patients with acute myocardial infarctionD E Hilleman, J M Gannon
The Annals of Pharmacotherapy|December 1, 2000
Aggrenox: a fixed-dose combination of aspirin and dipyridamoleT L Lenz, D E Hilleman
Pharmacotherapy|May 15, 2001
Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based reviewD E Hilleman, A L Bauman
Pageof 9